Gildan Activewear Inc. manufactures and sells various apparel products. It provides various activewear products, including T-shirts, fleece tops and bottoms, and sports shirts, polos, and tank tops under Gildan, Gildan Performance, Gildan Hammer, Gildan Softstyle, Gildan Heavy Cotton, Gildan Ultra Cotton, Gildan DryBlend, Gildan HeavyBlend, Comfort Colors, American Apparel, and Champion brands. The company also offers hosiery products comprising athletic; dress; and casual, liner, therapeutic, and workwear socks under Gildan, GoldToe, Signature Gold by GoldToe, GoldToe Edition, Peds, MediPeds, All Pro, and Powersox brands. In addition, it provides men's and boys' underwear products and ladies panties under Gildan and Gildan Platinum brands. The company sells its products to wholesale distributors, screenprinters, and embellishers in North America, Europe, the Asia-Pacific, and Latin America, as well as to retailers in North America and lifestyle brand companies. The company was formerly known as Textiles Gildan Inc. and changed its name to Gildan Activewear Inc. in March 1995. Gildan Activewear Inc. was founded in 1946 and is headquartered in Montreal, Canada.

Gildan Activewear Inc. Class A Sub. Vot.

In a report released yesterday, Chris Li CFA from Desjardins maintained a Buy rating on Gildan Activewear, with a price target of C$108.00. Li CFA ...

Desjardins Reaffirms Their Buy Rating on Gildan Activewear (GIL)

An announcement from Pearl Global Industries Limited ( ($IN:PGIL) ) is now available. Pearl Global Industries has announced that independent direct...

Pearl Global’s Independent Director Neha Khanna to Step Down After Completion of Tenure

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Edgewise Therapeutics (EWTX), Gilead Sciences (GILD)...

Analysts Offer Insights on Healthcare Companies: Edgewise Therapeutics (EWTX), Gilead Sciences (GILD) and Codexis (CDXS)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Irhythm Technologies (IRTC), Gilead Sciences (GILD) ...

Analysts Are Bullish on These Healthcare Stocks: Irhythm Technologies (IRTC), Gilead Sciences (GILD)

There’s a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on Gilat (GILT) and Block (XYZ) with bullish sentiments...

Analysts Are Bullish on These Technology Stocks: Gilat (GILT), Block (XYZ)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on OrthoPediatrics (KIDS), Gilead Sciences (GILD) and S...

Analysts Offer Insights on Healthcare Companies: OrthoPediatrics (KIDS), Gilead Sciences (GILD) and Savara (SVRA)

Stocks ended the week higher as investors looked past policy noise and leaned back into risk assets. The Dow Jones Industrial Average (DJIA) rose 0...

The Week That Was, The Week Ahead: Macro and Markets, June 14

Mizuho Securities analyst Salim Syed maintained a Buy rating on Gilead Sciences today and set a price target of $170.00. According to TipRanks, Sye...

Mizuho Securities Remains a Buy on Gilead Sciences (GILD)

Gilead Sciences ($GILD) announced an update on their ongoing clinical study. Gilead Sciences has launched a Phase 2 study titled “A Phase 2, Open L...

Gilead Advances Denikitug Trial in Tough-to-Treat Colorectal Cancer

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Establishment Labs Holdings (ESTA) and Gilead Scienc...

Analysts Offer Insights on Healthcare Companies: Establishment Labs Holdings (ESTA) and Gilead Sciences (GILD)

In a report released yesterday, Courtney Breen from Bernstein maintained a Buy rating on Gilead Sciences, with a price target of $160.00. The compa...

Gilead Sciences (GILD) Gets a Buy from Bernstein

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Gilead Sciences (GILD), Jazz Pharmaceuticals (JAZZ) ...

Wall Street Analysts Are Bullish on Top Healthcare Picks

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Gilead Sciences (GILD), Hims & Hers Health (HIMS) ...

Analysts Conflicted on These Healthcare Names: Gilead Sciences (GILD), Hims & Hers Health (HIMS) and Nurix Therapeutics (NRIX)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Gilead Sciences (GILD), Hinge Health, Inc. Class A (HNGE) and Moo...

Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD), Hinge Health, Inc. Class A (HNGE) and MoonLake Immunotherapeutics (MLTX)

An announcement from Pearl Global Industries Limited ( ($IN:PGIL) ) is now available. Pearl Global Industries Limited has announced that Whole-Time...

Pearl Global Announces Resignation of Whole-Time Director Shailesh Kumar

Gilead Sciences ($GILD) announced an update on their ongoing clinical study. The IDEAL Phase 3 study, officially titled “IDEAL: A 52-week, Double-b...

Gilead’s IDEAL PBC Trial Reaches Key Milestone, Setting Up a New Liver Disease Catalyst

There’s a lot to be optimistic about in the Consumer Cyclical sector as 2 analysts just weighed in on Kura Sushi USA (KRUS) and Gildan Activewear (...

Analysts’ Top Consumer Cyclical Picks: Kura Sushi USA (KRUS), Gildan Activewear (GIL)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Ardent Health Partners, Inc. (ARDT), Lemaitre Vascul...

Analysts Offer Insights on Healthcare Companies: Ardent Health Partners, Inc. (ARDT), Lemaitre Vascular (LMAT) and Gilead Sciences (GILD)

Scotiabank analyst Louise Chen maintained a Buy rating on Gilead Sciences today and set a price target of $177.00. Chen covers the Healthcare secto...

Scotiabank Sticks to Its Buy Rating for Gilead Sciences (GILD)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Travere Therapeutics (TVTX), Gilead Sciences (GILD) ...

Analysts Offer Insights on Healthcare Companies: Travere Therapeutics (TVTX), Gilead Sciences (GILD) and Celcuity (CELC)

In a report released today, Brian Abrahams from RBC Capital maintained a Hold rating on Gilead Sciences, with a price target of $122.00. According ...

Gilead Sciences (GILD) Gets a Hold from RBC Capital

Gilead Sciences ($GILD) announced an update on their ongoing clinical study. The Gilead Sciences (GILD) study, “Pioneering Research to Optimize Pre...

Gilead’s Lenacapavir PrEP Study: Real-World Data That Could Reshape the HIV Prevention Market

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Gilead Sciences (GILD) and Alkermes (ALKS) with bull...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	GIL	$52.09	+0.39%	1.89M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	GIL	$52.09	+0.4%	1.89M
3
4
5
6

GIL

GIL

Recent News for GIL

Get Gildan Activewear Inc. Class A Sub. Vot. Data in Excel

Get Gildan Activewear Inc. Class A Sub. Vot. Data in Excel